444 related articles for article (PubMed ID: 34087454)
1. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance.
Zhang X; Liu X; Zhou W; Du Q; Yang M; Ding Y; Hu R
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1179-1199. PubMed ID: 34087454
[TBL] [Abstract][Full Text] [Related]
2. IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice.
Thaker AI; Rao MS; Bishnupuri KS; Kerr TA; Foster L; Marinshaw JM; Newberry RD; Stenson WF; Ciorba MA
Gastroenterology; 2013 Aug; 145(2):416-25.e1-4. PubMed ID: 23669411
[TBL] [Abstract][Full Text] [Related]
3. 1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells.
Liu X; Zhou W; Zhang X; Ding Y; Du Q; Hu R
Int J Cancer; 2018 Sep; 143(6):1516-1529. PubMed ID: 29607498
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell-expressed IDO alleviates atherosclerosis by expanding CD4
Wang F; Liu M; Ma D; Cai Z; Liu L; Wang J; Zhang W; Zhao L; Zhai C; Xu Y
Int Immunopharmacol; 2023 Mar; 116():109758. PubMed ID: 36706593
[TBL] [Abstract][Full Text] [Related]
5. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine.
Campesato LF; Budhu S; Tchaicha J; Weng CH; Gigoux M; Cohen IJ; Redmond D; Mangarin L; Pourpe S; Liu C; Zappasodi R; Zamarin D; Cavanaugh J; Castro AC; Manfredi MG; McGovern K; Merghoub T; Wolchok JD
Nat Commun; 2020 Aug; 11(1):4011. PubMed ID: 32782249
[TBL] [Abstract][Full Text] [Related]
6. IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells
Amobi-McCloud A; Muthuswamy R; Battaglia S; Yu H; Liu T; Wang J; Putluri V; Singh PK; Qian F; Huang RY; Putluri N; Tsuji T; Lugade AA; Liu S; Odunsi K
Front Immunol; 2021; 12():678999. PubMed ID: 34025677
[TBL] [Abstract][Full Text] [Related]
7. Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice.
Hoshi M; Osawa Y; Nakamoto K; Morita N; Yamamoto Y; Ando T; Tashita C; Nabeshima T; Saito K
Toxicology; 2020 May; 438():152458. PubMed ID: 32289347
[TBL] [Abstract][Full Text] [Related]
8. Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis.
Labadie BW; Bao R; Luke JJ
Clin Cancer Res; 2019 Mar; 25(5):1462-1471. PubMed ID: 30377198
[TBL] [Abstract][Full Text] [Related]
9.
Fong W; Li Q; Ji F; Liang W; Lau HCH; Kang X; Liu W; To KK; Zuo Z; Li X; Zhang X; Sung JJ; Yu J
Gut; 2023 Nov; 72(12):2272-2285. PubMed ID: 37770127
[TBL] [Abstract][Full Text] [Related]
10. DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota.
Zhao LP; Wu J; Quan W; Zhou Y; Hong H; Niu GY; Li T; Huang SB; Qiao CM; Zhao WJ; Cui C; Shen YQ
Front Immunol; 2022; 13():1089200. PubMed ID: 36776388
[TBL] [Abstract][Full Text] [Related]
11. Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy.
Shi J; Chen C; Ju R; Wang Q; Li J; Guo L; Ye C; Zhang D
J Immunother Cancer; 2019 Sep; 7(1):246. PubMed ID: 31511064
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Upregulation of Indoleamine 2,3-Dioxygenase 1 Promotes Proliferation and Metastasis of Hepatocellular Carcinoma Cells via Coordinated Activation of AhR and β-Catenin Signaling.
Chen CT; Wu PH; Hu CC; Nien HC; Wang JT; Sheu JC; Chow LP
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769098
[TBL] [Abstract][Full Text] [Related]
13. Functional role of kynurenine and aryl hydrocarbon receptor axis in chronic rhinosinusitis with nasal polyps.
Wang H; Do DC; Liu J; Wang B; Qu J; Ke X; Luo X; Tang HM; Tang HL; Hu C; Anderson ME; Liu Z; Gao P
J Allergy Clin Immunol; 2018 Feb; 141(2):586-600.e6. PubMed ID: 28689792
[TBL] [Abstract][Full Text] [Related]
14. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism.
Nguyen NT; Kimura A; Nakahama T; Chinen I; Masuda K; Nohara K; Fujii-Kuriyama Y; Kishimoto T
Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19961-6. PubMed ID: 21041655
[TBL] [Abstract][Full Text] [Related]
15. Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.
Cheong JE; Sun L
Trends Pharmacol Sci; 2018 Mar; 39(3):307-325. PubMed ID: 29254698
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of acute lethal pulmonary inflammation by the IDO-AhR pathway.
Lee SM; Park HY; Suh YS; Yoon EH; Kim J; Jang WH; Lee WS; Park SG; Choi IW; Choi I; Kang SW; Yun H; Teshima T; Kwon B; Seo SK
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5881-E5890. PubMed ID: 28673995
[TBL] [Abstract][Full Text] [Related]
17. Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia
Atene CG; Fiorcari S; Mesini N; Alboni S; Martinelli S; Maccaferri M; Leonardi G; Potenza L; Luppi M; Maffei R; Marasca R
Front Immunol; 2022; 13():832263. PubMed ID: 35371054
[TBL] [Abstract][Full Text] [Related]
18. Targeting of neuroblastoma cells through Kynurenine-AHR pathway inhibition.
Dos Santos IL; Mitchell M; Nogueira PAS; Lafita-Navarro MC; Perez-Castro L; Eriom J; Kilgore JA; Williams NS; Guo L; Xu L; Conacci-Sorrell M
FEBS J; 2024 May; 291(10):2172-2190. PubMed ID: 38431776
[TBL] [Abstract][Full Text] [Related]
19. Alpinetin exerts anti-colitis efficacy by activating AhR, regulating miR-302/DNMT-1/CREB signals, and therefore promoting Treg differentiation.
Lv Q; Shi C; Qiao S; Cao N; Guan C; Dai Y; Wei Z
Cell Death Dis; 2018 Aug; 9(9):890. PubMed ID: 30166541
[TBL] [Abstract][Full Text] [Related]
20. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
